tradingkey.logo
tradingkey.logo

Amneal Pharmaceuticals Inc

AMRX
12.925USD
+0.055+0.43%
取引時間 ET15分遅れの株価
4.06B時価総額
725.31直近12ヶ月PER

Amneal Pharmaceuticals Inc

12.925
+0.055+0.43%

詳細情報 Amneal Pharmaceuticals Inc 企業名

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Incの企業情報

企業コードAMRX
会社名Amneal Pharmaceuticals Inc
上場日Nov 18, 2009
最高経営責任者「CEO」Patel (Chintu)
従業員数8100
証券種類Ordinary Share
決算期末Nov 18
本社所在地400 Crossing Boulevard, 3rd Floor
都市BRIDGEWATER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号08807
電話番号19089473120
ウェブサイトhttps://amneal.com/
企業コードAMRX
上場日Nov 18, 2009
最高経営責任者「CEO」Patel (Chintu)

Amneal Pharmaceuticals Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
25.62M
--
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-8.60%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+32.21%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+16.38%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
191.40K
--
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+75.39%
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Mr. Paul M. Meister
Mr. Paul M. Meister
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. John J. Kiely
Mr. John J. Kiely
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
25.62M
--
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-8.60%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+32.21%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+16.38%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
191.40K
--
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+75.39%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Oral solid
178.26M
24.60%
Distribution
99.66M
13.76%
Central Nervous System
83.42M
11.51%
Other dosage forms
68.19M
9.41%
Auto-injector
66.59M
9.19%
他の
228.38M
31.52%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Oral solid
178.26M
24.60%
Distribution
99.66M
13.76%
Central Nervous System
83.42M
11.51%
Other dosage forms
68.19M
9.41%
Auto-injector
66.59M
9.19%
他の
228.38M
31.52%

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Patel (Tushar Bhikhubhai)
15.45%
Patel (Chintu)
8.15%
Patel (Dipan)
7.58%
Patel (Chirag K)
7.04%
Akram (Mahesh)
6.54%
他の
55.24%
株主統計
株主統計
比率
Patel (Tushar Bhikhubhai)
15.45%
Patel (Chintu)
8.15%
Patel (Dipan)
7.58%
Patel (Chirag K)
7.04%
Akram (Mahesh)
6.54%
他の
55.24%
種類
株主統計
比率
Individual Investor
46.38%
Investment Advisor
19.36%
Investment Advisor/Hedge Fund
11.79%
Hedge Fund
11.60%
Private Equity
3.92%
Research Firm
1.93%
Pension Fund
0.27%
Bank and Trust
0.19%
Family Office
0.03%
他の
4.54%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
448
154.72M
55.65%
+68.38K
2025Q3
455
154.66M
56.61%
+8.55M
2025Q2
432
145.89M
53.25%
+6.99M
2025Q1
416
138.78M
50.16%
-18.42M
2024Q4
398
129.01M
49.64%
-14.17M
2024Q3
380
143.02M
47.07%
+6.97M
2024Q2
372
135.82M
34.71%
+37.56M
2024Q1
356
97.40M
32.81%
-3.83M
2023Q4
348
89.35M
29.61%
+7.08M
2023Q3
338
82.03M
56.21%
+4.32M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Patel (Tushar Bhikhubhai)
48.58M
15.47%
-5.00M
-9.33%
Mar 14, 2025
Patel (Chintu)
25.62M
8.16%
+351.47K
+1.39%
Mar 14, 2025
Patel (Dipan)
23.83M
7.6%
--
--
Mar 14, 2025
Patel (Chirag K)
22.13M
7.05%
--
--
Aug 06, 2025
Akram (Mahesh)
20.56M
6.55%
-6.30M
-23.45%
Mar 31, 2025
The Vanguard Group, Inc.
17.49M
5.57%
+1.78M
+11.34%
Jun 30, 2025
Rubric Capital Management LP
11.71M
3.73%
+974.36K
+9.08%
Jun 30, 2025
TPG Capital, L.P.
12.33M
3.93%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
10.64M
3.39%
-499.58K
-4.49%
Jun 30, 2025
Citadel Advisors LLC
5.62M
1.79%
-1.87M
-24.92%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco Pharmaceuticals ETF
3.08%
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2%
Invesco Dorsey Wright Healthcare Momentum ETF
0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
0.83%
First Trust NASDAQ Pharmaceuticals ETF
0.78%
First Trust Small Cap Growth AlphaDEX Fund
0.72%
iShares U.S. Pharmaceuticals ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.48%
WisdomTree US SmallCap Fund
0.36%
詳細を見る
Invesco Pharmaceuticals ETF
比率3.08%
State Street SPDR S&P Pharmaceuticals ETF
比率2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率2%
Invesco Dorsey Wright Healthcare Momentum ETF
比率0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
比率0.83%
First Trust NASDAQ Pharmaceuticals ETF
比率0.78%
First Trust Small Cap Growth AlphaDEX Fund
比率0.72%
iShares U.S. Pharmaceuticals ETF
比率0.68%
ProShares Ultra Nasdaq Biotechnology
比率0.48%
WisdomTree US SmallCap Fund
比率0.36%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Amneal Pharmaceuticals Incの上位5名の株主は誰ですか?

Amneal Pharmaceuticals Incの上位5名の株主は以下のとおりです。
Patel (Tushar Bhikhubhai)は48.58M株を保有しており、これは全体の15.47%に相当します。
Patel (Chintu)は25.62M株を保有しており、これは全体の8.16%に相当します。
Patel (Dipan)は23.83M株を保有しており、これは全体の7.60%に相当します。
Patel (Chirag K)は22.13M株を保有しており、これは全体の7.05%に相当します。
Akram (Mahesh)は20.56M株を保有しており、これは全体の6.55%に相当します。

Amneal Pharmaceuticals Incの株主タイプ上位3種は何ですか?

Amneal Pharmaceuticals Incの株主タイプ上位3種は、
Patel (Tushar Bhikhubhai)
Patel (Chintu)
Patel (Dipan)

Amneal Pharmaceuticals Inc(AMRX)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Amneal Pharmaceuticals Incの株式を保有している機関は448社あり、保有株式の総市場価値は約154.72Mで、全体の55.65%を占めています。2025Q3と比較して、機関の持ち株は-0.96%増加しています。

Amneal Pharmaceuticals Incの最大の収益源は何ですか?

FY2025Q2において、Oral solid部門がAmneal Pharmaceuticals Incにとって最大の収益を生み出しており、その金額は178.26Mで、全収益の24.60%を占めています。
KeyAI